Login / Signup

Donanemab: An innovative solution for Alzheimer's disease?

Muhammad Shaheer Bin FaheemGhazal Ishaque
Published in: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology (2024)
Keyphrases
  • cognitive decline
  • mild cognitive impairment